Iranian Journal of Neurology 2017. 16(3):118-124.

Evaluation of non-motor symptoms and their impact on quality of life in patients with Parkinson’s disease, Isfahan, Iran
Mehri Salari, Ahmad Chitsaz, Masoud Etemadifar, Mohammad Reza Najafi, Omid Mirmosayyeb, Maryam Bemanalizadeh, Fatemeh Panahi, Hosna Mirzajani


Background: Parkinson’s disease (PD) is diagnosed on the basis of motor symptoms, but non-motor symptoms (NMS) have high prevalence in PD and often antecede motor symptoms for years and cause severe disability. This study was conducted to determine the prevalence of NMS in patients with PD.

Methods: This cross-sectional study was performed in Isfahan, Iran, on patients with PD. The prevalence of NMS was evaluated by the NMS questionnaire, the NMS scale, and Parkinson's disease questionnaire-39 (PDQ-39). The Mini-Mental Status Examination (MMSE) was used for assessing cognition.

Results: A total of 81 patients, including 60 men and 21 women, were recruited for this study. The prevalence of NMS was 100%, and the most commonly reported symptom was fatigue (87.7%); there was a strong correlation between NMS and the quality of life (QOL) of patients with PD (P < 0.001).

Conclusion: This study showed that NMS are highly prevalent in the PD population and adversely affect QOL in these patients. Early diagnosis and treatment can improve QOL and can help in disability management of patients with PD.


Non-Motor Symptoms; Parkinson Disease; Quality of Life

Full Text:



Schapira AH. The measurement and importance of non-motor symptoms in Parkinson disease. Eur J Neurol 2015;22(1): 2-3.

Arnao V, Cinturino A, Valentino F, Perini V, Mastrilli S, Bellavia G, et al. In patients with Parkinson diseaseautonomic symptoms are frequent and associated with other non-motor symptoms. Clin Auton Res 2015; 25(5):301-7.

Jellinger KA. Neuropathobiology of non-motor symptoms in Parkinson disease. J Neural Transm (Vienna) 2015;122(10): 1429-40.

Chou KL, Taylor JL, Patil PG. The MDS-UPDRS tracks motor and non- motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease. Parkinsonism Relat Disord 2013; 19(11): 966-9.

Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O'Brien JTBrooks DJ, et al.The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 2013;80(3): 276-81.

Li H, Zhang M, Chen L, Zhang J, Pei Z, Hu A, et al. Nonmotor symptoms areindependently associated with impaired healthrelated quality of life in Chinese patients with Parkinson's disease. Mov Disord 2010; 25(16): 2740-6.

Hoehn MM, Yahr MD. Parkinsonism: Onset, progression and mortality.Neurology 1967; 17(5): 427-42.

Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K Odin P, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: Tthe NMSQuest study. Mov Disord 2006; 21(7): 916-23.

Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. Mov Disord 2007; 22(13): 1901-11.

Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and wellbeing for individuals with Parkinson's disease. Qual Life Res1995; 4(3): 241-8.

Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical methodfor grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3): 189-98.

Seyedian M, Falah M, Nourouzian M, Nejat S, Delavar A, Ghasemzadeh HA. Validity of the Farsi version of mini- mental state examination. J Med Counc I R Iran 2008; 25(4): 408-14. [In Persian].

Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P,et al. Movement Disorder Society- sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23(15): 2129-70.

O'Sullivan SS, Williams DR, Gallagher DA, Massey LA, SilveiraMoriyama L, Lees AJ. Nonmotor symptoms aspresenting complaints in Parkinson's disease: A clinicopathological study. MovDisord 2008; 23(1): 101-6.

Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009;24(11): 1641-9.

Azmin S, Khairul Anuar AM, Tan HJ, Nafisah WY, Raymond AA, Hanita O, et al. Nonmotor symptoms in a Malaysian Parkinson's disease population. Parkinsons Dis 2014; 2014: 472157.

Cosentino C, Nunez Y, Torres L.Frequency of non-motor symptoms in Peruvian patients with Parkinson's disease. Arq Neuropsiquiatr 2013; 71(4):216-9.

Estrada-Bellmann I, Camara-LemarroyCR,CalderonHernandez HJ, Rocha- Anaya JJ, Villareal-Velazquez HJ. Non-motor symptoms and quality of life in patients with Parkinson's disease in Northeastern Mexico. Acta Neurol Belg 2016; 116(2): 157-61.

Dogan VB, Koksal A, Dirican A, Baybas S, Dirican A, Dogan GB. Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson's disease. Neurol Sci 2015;36(12): 2221-6.

Kang SY, Ma HI, Lim YM, Hwang SH, Kim YJ. Fatigue in drug-naive Parkinson's disease. Eur Neurol 2013;70(1-2): 59-64.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.